nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—CYP2E1—Mitoxantrone—lymphatic system cancer	0.141	0.29	CbGbCtD
Nitrazepam—ABCB1—Mitoxantrone—lymphatic system cancer	0.0713	0.147	CbGbCtD
Nitrazepam—CYP3A4—Cytarabine—lymphatic system cancer	0.062	0.128	CbGbCtD
Nitrazepam—CYP3A4—Teniposide—lymphatic system cancer	0.0611	0.126	CbGbCtD
Nitrazepam—ABCB1—Vincristine—lymphatic system cancer	0.0491	0.101	CbGbCtD
Nitrazepam—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0427	0.0878	CbGbCtD
Nitrazepam—ABCB1—Methotrexate—lymphatic system cancer	0.0297	0.0611	CbGbCtD
Nitrazepam—CYP3A4—Vincristine—lymphatic system cancer	0.0294	0.0604	CbGbCtD
Nitrazepam—Pneumonia aspiration—Carmustine—lymphatic system cancer	0.0238	0.0464	CcSEcCtD
Nitrazepam—Digestion impaired—Fludarabine—lymphatic system cancer	0.0122	0.0237	CcSEcCtD
Nitrazepam—Numbness—Fludarabine—lymphatic system cancer	0.00981	0.0191	CcSEcCtD
Nitrazepam—Sensory loss—Fludarabine—lymphatic system cancer	0.00938	0.0183	CcSEcCtD
Nitrazepam—Jaundice—Mechlorethamine—lymphatic system cancer	0.00684	0.0133	CcSEcCtD
Nitrazepam—Aggression—Bleomycin—lymphatic system cancer	0.00678	0.0132	CcSEcCtD
Nitrazepam—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00655	0.0128	CcSEcCtD
Nitrazepam—Numbness—Vincristine—lymphatic system cancer	0.00599	0.0117	CcSEcCtD
Nitrazepam—Sensory loss—Vincristine—lymphatic system cancer	0.00573	0.0112	CcSEcCtD
Nitrazepam—Thinking abnormal—Carmustine—lymphatic system cancer	0.00568	0.0111	CcSEcCtD
Nitrazepam—Gait disturbance—Carmustine—lymphatic system cancer	0.00533	0.0104	CcSEcCtD
Nitrazepam—Coordination abnormal—Carmustine—lymphatic system cancer	0.0053	0.0103	CcSEcCtD
Nitrazepam—Dysphagia—Fludarabine—lymphatic system cancer	0.0051	0.00993	CcSEcCtD
Nitrazepam—Gait disturbance—Vincristine—lymphatic system cancer	0.00509	0.00991	CcSEcCtD
Nitrazepam—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.00502	0.00978	CcSEcCtD
Nitrazepam—Urinary incontinence—Carmustine—lymphatic system cancer	0.00502	0.00978	CcSEcCtD
Nitrazepam—Sweating—Teniposide—lymphatic system cancer	0.00496	0.00966	CcSEcCtD
Nitrazepam—Vertigo—Mechlorethamine—lymphatic system cancer	0.00493	0.0096	CcSEcCtD
Nitrazepam—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00491	0.00956	CcSEcCtD
Nitrazepam—Disorientation—Bleomycin—lymphatic system cancer	0.00484	0.00942	CcSEcCtD
Nitrazepam—Pneumonia—Fludarabine—lymphatic system cancer	0.00457	0.00891	CcSEcCtD
Nitrazepam—Mental disability—Carmustine—lymphatic system cancer	0.00452	0.00879	CcSEcCtD
Nitrazepam—Infection—Mechlorethamine—lymphatic system cancer	0.00445	0.00866	CcSEcCtD
Nitrazepam—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00406	0.00791	CcSEcCtD
Nitrazepam—Amnesia—Carmustine—lymphatic system cancer	0.00402	0.00783	CcSEcCtD
Nitrazepam—Diplopia—Carmustine—lymphatic system cancer	0.00378	0.00736	CcSEcCtD
Nitrazepam—Agitation—Teniposide—lymphatic system cancer	0.00372	0.00724	CcSEcCtD
Nitrazepam—Leukopenia—Teniposide—lymphatic system cancer	0.00362	0.00705	CcSEcCtD
Nitrazepam—Ataxia—Carmustine—lymphatic system cancer	0.00355	0.00692	CcSEcCtD
Nitrazepam—Ataxia—Vincristine—lymphatic system cancer	0.00339	0.0066	CcSEcCtD
Nitrazepam—Pneumonia—Bleomycin—lymphatic system cancer	0.00335	0.00653	CcSEcCtD
Nitrazepam—Muscular weakness—Carmustine—lymphatic system cancer	0.00333	0.00649	CcSEcCtD
Nitrazepam—Confusional state—Teniposide—lymphatic system cancer	0.00333	0.00648	CcSEcCtD
Nitrazepam—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0033	0.00642	CcSEcCtD
Nitrazepam—Infection—Teniposide—lymphatic system cancer	0.00328	0.00639	CcSEcCtD
Nitrazepam—Agitation—Fludarabine—lymphatic system cancer	0.00327	0.00636	CcSEcCtD
Nitrazepam—Dysphagia—Carmustine—lymphatic system cancer	0.00326	0.00636	CcSEcCtD
Nitrazepam—Malaise—Fludarabine—lymphatic system cancer	0.00321	0.00624	CcSEcCtD
Nitrazepam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00319	0.00621	CcSEcCtD
Nitrazepam—Leukopenia—Fludarabine—lymphatic system cancer	0.00318	0.0062	CcSEcCtD
Nitrazepam—Muscular weakness—Vincristine—lymphatic system cancer	0.00318	0.00619	CcSEcCtD
Nitrazepam—Pruritus—Mechlorethamine—lymphatic system cancer	0.00317	0.00617	CcSEcCtD
Nitrazepam—Hypotension—Teniposide—lymphatic system cancer	0.00308	0.00601	CcSEcCtD
Nitrazepam—Convulsion—Fludarabine—lymphatic system cancer	0.00308	0.006	CcSEcCtD
Nitrazepam—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00306	0.00597	CcSEcCtD
Nitrazepam—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00298	0.0058	CcSEcCtD
Nitrazepam—Dyspnoea—Teniposide—lymphatic system cancer	0.00294	0.00573	CcSEcCtD
Nitrazepam—Pneumonia—Carmustine—lymphatic system cancer	0.00293	0.0057	CcSEcCtD
Nitrazepam—Confusional state—Fludarabine—lymphatic system cancer	0.00292	0.0057	CcSEcCtD
Nitrazepam—Infection—Fludarabine—lymphatic system cancer	0.00288	0.00561	CcSEcCtD
Nitrazepam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00285	0.00554	CcSEcCtD
Nitrazepam—Rash—Mechlorethamine—lymphatic system cancer	0.00282	0.0055	CcSEcCtD
Nitrazepam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00282	0.00549	CcSEcCtD
Nitrazepam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.0028	0.00546	CcSEcCtD
Nitrazepam—Pneumonia—Vincristine—lymphatic system cancer	0.00279	0.00544	CcSEcCtD
Nitrazepam—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00272	0.0053	CcSEcCtD
Nitrazepam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00272	0.0053	CcSEcCtD
Nitrazepam—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00271	0.00527	CcSEcCtD
Nitrazepam—Sweating—Vincristine—lymphatic system cancer	0.00266	0.00519	CcSEcCtD
Nitrazepam—Nausea—Mechlorethamine—lymphatic system cancer	0.00266	0.00518	CcSEcCtD
Nitrazepam—Jaundice—Mitoxantrone—lymphatic system cancer	0.00264	0.00514	CcSEcCtD
Nitrazepam—Paraesthesia—Fludarabine—lymphatic system cancer	0.0026	0.00507	CcSEcCtD
Nitrazepam—Hallucination—Carmustine—lymphatic system cancer	0.0026	0.00506	CcSEcCtD
Nitrazepam—Hypoaesthesia—Carmustine—lymphatic system cancer	0.0026	0.00506	CcSEcCtD
Nitrazepam—Sweating—Mitoxantrone—lymphatic system cancer	0.00259	0.00505	CcSEcCtD
Nitrazepam—Dyspnoea—Fludarabine—lymphatic system cancer	0.00259	0.00504	CcSEcCtD
Nitrazepam—Dyspepsia—Fludarabine—lymphatic system cancer	0.00255	0.00497	CcSEcCtD
Nitrazepam—Dysarthria—Methotrexate—lymphatic system cancer	0.00255	0.00496	CcSEcCtD
Nitrazepam—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00253	0.00492	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0025	0.00488	CcSEcCtD
Nitrazepam—Fatigue—Fludarabine—lymphatic system cancer	0.0025	0.00487	CcSEcCtD
Nitrazepam—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00248	0.00483	CcSEcCtD
Nitrazepam—Hallucination—Vincristine—lymphatic system cancer	0.00248	0.00483	CcSEcCtD
Nitrazepam—Constipation—Fludarabine—lymphatic system cancer	0.00248	0.00483	CcSEcCtD
Nitrazepam—Hypersensitivity—Teniposide—lymphatic system cancer	0.00243	0.00474	CcSEcCtD
Nitrazepam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00239	0.00466	CcSEcCtD
Nitrazepam—Asthenia—Teniposide—lymphatic system cancer	0.00237	0.00461	CcSEcCtD
Nitrazepam—Malaise—Bleomycin—lymphatic system cancer	0.00235	0.00458	CcSEcCtD
Nitrazepam—Pruritus—Teniposide—lymphatic system cancer	0.00233	0.00455	CcSEcCtD
Nitrazepam—Leukopenia—Bleomycin—lymphatic system cancer	0.00233	0.00454	CcSEcCtD
Nitrazepam—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00233	0.00453	CcSEcCtD
Nitrazepam—Diarrhoea—Teniposide—lymphatic system cancer	0.00226	0.0044	CcSEcCtD
Nitrazepam—Confusional state—Bleomycin—lymphatic system cancer	0.00214	0.00418	CcSEcCtD
Nitrazepam—Vision blurred—Carmustine—lymphatic system cancer	0.00214	0.00417	CcSEcCtD
Nitrazepam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00214	0.00416	CcSEcCtD
Nitrazepam—Tremor—Carmustine—lymphatic system cancer	0.00213	0.00415	CcSEcCtD
Nitrazepam—Infection—Bleomycin—lymphatic system cancer	0.00211	0.00411	CcSEcCtD
Nitrazepam—Vomiting—Teniposide—lymphatic system cancer	0.0021	0.00409	CcSEcCtD
Nitrazepam—Agitation—Carmustine—lymphatic system cancer	0.00209	0.00407	CcSEcCtD
Nitrazepam—Asthenia—Fludarabine—lymphatic system cancer	0.00208	0.00405	CcSEcCtD
Nitrazepam—Rash—Teniposide—lymphatic system cancer	0.00208	0.00405	CcSEcCtD
Nitrazepam—Dermatitis—Teniposide—lymphatic system cancer	0.00208	0.00405	CcSEcCtD
Nitrazepam—Headache—Teniposide—lymphatic system cancer	0.00207	0.00403	CcSEcCtD
Nitrazepam—Pruritus—Fludarabine—lymphatic system cancer	0.00205	0.004	CcSEcCtD
Nitrazepam—Leukopenia—Carmustine—lymphatic system cancer	0.00204	0.00397	CcSEcCtD
Nitrazepam—Agitation—Vincristine—lymphatic system cancer	0.002	0.00389	CcSEcCtD
Nitrazepam—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00199	0.00388	CcSEcCtD
Nitrazepam—Hypotension—Bleomycin—lymphatic system cancer	0.00199	0.00387	CcSEcCtD
Nitrazepam—Diarrhoea—Fludarabine—lymphatic system cancer	0.00198	0.00387	CcSEcCtD
Nitrazepam—Convulsion—Carmustine—lymphatic system cancer	0.00197	0.00384	CcSEcCtD
Nitrazepam—Nausea—Teniposide—lymphatic system cancer	0.00196	0.00382	CcSEcCtD
Nitrazepam—Vertigo—Vincristine—lymphatic system cancer	0.00195	0.0038	CcSEcCtD
Nitrazepam—Leukopenia—Vincristine—lymphatic system cancer	0.00194	0.00379	CcSEcCtD
Nitrazepam—Anxiety—Carmustine—lymphatic system cancer	0.00193	0.00376	CcSEcCtD
Nitrazepam—Paraesthesia—Bleomycin—lymphatic system cancer	0.00191	0.00372	CcSEcCtD
Nitrazepam—Malaise—Mitoxantrone—lymphatic system cancer	0.00191	0.00371	CcSEcCtD
Nitrazepam—Dyspnoea—Bleomycin—lymphatic system cancer	0.0019	0.00369	CcSEcCtD
Nitrazepam—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00189	0.00369	CcSEcCtD
Nitrazepam—Convulsion—Vincristine—lymphatic system cancer	0.00188	0.00366	CcSEcCtD
Nitrazepam—Confusional state—Carmustine—lymphatic system cancer	0.00187	0.00365	CcSEcCtD
Nitrazepam—Infection—Carmustine—lymphatic system cancer	0.00184	0.00359	CcSEcCtD
Nitrazepam—Vomiting—Fludarabine—lymphatic system cancer	0.00184	0.00359	CcSEcCtD
Nitrazepam—Convulsion—Mitoxantrone—lymphatic system cancer	0.00183	0.00357	CcSEcCtD
Nitrazepam—Rash—Fludarabine—lymphatic system cancer	0.00183	0.00356	CcSEcCtD
Nitrazepam—Dermatitis—Fludarabine—lymphatic system cancer	0.00183	0.00356	CcSEcCtD
Nitrazepam—Headache—Fludarabine—lymphatic system cancer	0.00182	0.00354	CcSEcCtD
Nitrazepam—Anxiety—Mitoxantrone—lymphatic system cancer	0.00179	0.00349	CcSEcCtD
Nitrazepam—Lethargy—Methotrexate—lymphatic system cancer	0.00179	0.00348	CcSEcCtD
Nitrazepam—Infection—Vincristine—lymphatic system cancer	0.00176	0.00343	CcSEcCtD
Nitrazepam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00175	0.00341	CcSEcCtD
Nitrazepam—Confusional state—Mitoxantrone—lymphatic system cancer	0.00174	0.00339	CcSEcCtD
Nitrazepam—Hypotension—Carmustine—lymphatic system cancer	0.00173	0.00338	CcSEcCtD
Nitrazepam—Nausea—Fludarabine—lymphatic system cancer	0.00172	0.00336	CcSEcCtD
Nitrazepam—Infection—Mitoxantrone—lymphatic system cancer	0.00171	0.00334	CcSEcCtD
Nitrazepam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00171	0.00334	CcSEcCtD
Nitrazepam—Shock—Mitoxantrone—lymphatic system cancer	0.0017	0.00331	CcSEcCtD
Nitrazepam—Irritability—Methotrexate—lymphatic system cancer	0.00167	0.00325	CcSEcCtD
Nitrazepam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00167	0.00325	CcSEcCtD
Nitrazepam—Paraesthesia—Carmustine—lymphatic system cancer	0.00167	0.00325	CcSEcCtD
Nitrazepam—Hypotension—Vincristine—lymphatic system cancer	0.00166	0.00322	CcSEcCtD
Nitrazepam—Dyspnoea—Carmustine—lymphatic system cancer	0.00166	0.00322	CcSEcCtD
Nitrazepam—Somnolence—Carmustine—lymphatic system cancer	0.00165	0.00321	CcSEcCtD
Nitrazepam—Ataxia—Methotrexate—lymphatic system cancer	0.00165	0.0032	CcSEcCtD
Nitrazepam—Hypotension—Mitoxantrone—lymphatic system cancer	0.00161	0.00314	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.0016	0.00312	CcSEcCtD
Nitrazepam—Paraesthesia—Vincristine—lymphatic system cancer	0.00159	0.0031	CcSEcCtD
Nitrazepam—Constipation—Carmustine—lymphatic system cancer	0.00159	0.00309	CcSEcCtD
Nitrazepam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00157	0.00305	CcSEcCtD
Nitrazepam—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00155	0.00302	CcSEcCtD
Nitrazepam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00154	0.003	CcSEcCtD
Nitrazepam—Somnolence—Mitoxantrone—lymphatic system cancer	0.00153	0.00299	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00153	0.00298	CcSEcCtD
Nitrazepam—Feeling abnormal—Carmustine—lymphatic system cancer	0.00153	0.00298	CcSEcCtD
Nitrazepam—Fatigue—Vincristine—lymphatic system cancer	0.00153	0.00298	CcSEcCtD
Nitrazepam—Asthenia—Bleomycin—lymphatic system cancer	0.00153	0.00297	CcSEcCtD
Nitrazepam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00152	0.00296	CcSEcCtD
Nitrazepam—Constipation—Vincristine—lymphatic system cancer	0.00152	0.00295	CcSEcCtD
Nitrazepam—Pruritus—Bleomycin—lymphatic system cancer	0.0015	0.00293	CcSEcCtD
Nitrazepam—Fatigue—Mitoxantrone—lymphatic system cancer	0.00149	0.0029	CcSEcCtD
Nitrazepam—Constipation—Mitoxantrone—lymphatic system cancer	0.00148	0.00287	CcSEcCtD
Nitrazepam—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00145	0.00282	CcSEcCtD
Nitrazepam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00142	0.00277	CcSEcCtD
Nitrazepam—Hypersensitivity—Carmustine—lymphatic system cancer	0.00137	0.00266	CcSEcCtD
Nitrazepam—Pneumonia—Methotrexate—lymphatic system cancer	0.00136	0.00264	CcSEcCtD
Nitrazepam—Vomiting—Bleomycin—lymphatic system cancer	0.00135	0.00263	CcSEcCtD
Nitrazepam—Drowsiness—Methotrexate—lymphatic system cancer	0.00135	0.00263	CcSEcCtD
Nitrazepam—Rash—Bleomycin—lymphatic system cancer	0.00134	0.00261	CcSEcCtD
Nitrazepam—Dermatitis—Bleomycin—lymphatic system cancer	0.00134	0.00261	CcSEcCtD
Nitrazepam—Asthenia—Carmustine—lymphatic system cancer	0.00133	0.00259	CcSEcCtD
Nitrazepam—Hypersensitivity—Vincristine—lymphatic system cancer	0.00131	0.00254	CcSEcCtD
Nitrazepam—Sweating—Methotrexate—lymphatic system cancer	0.00129	0.00252	CcSEcCtD
Nitrazepam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00127	0.00248	CcSEcCtD
Nitrazepam—Asthenia—Vincristine—lymphatic system cancer	0.00127	0.00248	CcSEcCtD
Nitrazepam—Diarrhoea—Carmustine—lymphatic system cancer	0.00127	0.00247	CcSEcCtD
Nitrazepam—Nausea—Bleomycin—lymphatic system cancer	0.00126	0.00246	CcSEcCtD
Nitrazepam—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00126	0.00245	CcSEcCtD
Nitrazepam—Asthenia—Mitoxantrone—lymphatic system cancer	0.00124	0.00241	CcSEcCtD
Nitrazepam—Dizziness—Carmustine—lymphatic system cancer	0.00123	0.00239	CcSEcCtD
Nitrazepam—Diarrhoea—Vincristine—lymphatic system cancer	0.00121	0.00236	CcSEcCtD
Nitrazepam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00118	0.0023	CcSEcCtD
Nitrazepam—Vomiting—Carmustine—lymphatic system cancer	0.00118	0.0023	CcSEcCtD
Nitrazepam—Dizziness—Vincristine—lymphatic system cancer	0.00117	0.00228	CcSEcCtD
Nitrazepam—Rash—Carmustine—lymphatic system cancer	0.00117	0.00228	CcSEcCtD
Nitrazepam—Dermatitis—Carmustine—lymphatic system cancer	0.00117	0.00228	CcSEcCtD
Nitrazepam—Headache—Carmustine—lymphatic system cancer	0.00116	0.00226	CcSEcCtD
Nitrazepam—Vomiting—Vincristine—lymphatic system cancer	0.00113	0.00219	CcSEcCtD
Nitrazepam—Rash—Vincristine—lymphatic system cancer	0.00112	0.00218	CcSEcCtD
Nitrazepam—Dermatitis—Vincristine—lymphatic system cancer	0.00112	0.00217	CcSEcCtD
Nitrazepam—Headache—Vincristine—lymphatic system cancer	0.00111	0.00216	CcSEcCtD
Nitrazepam—Nausea—Carmustine—lymphatic system cancer	0.0011	0.00215	CcSEcCtD
Nitrazepam—Vomiting—Mitoxantrone—lymphatic system cancer	0.0011	0.00214	CcSEcCtD
Nitrazepam—Rash—Mitoxantrone—lymphatic system cancer	0.00109	0.00212	CcSEcCtD
Nitrazepam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00109	0.00212	CcSEcCtD
Nitrazepam—Headache—Mitoxantrone—lymphatic system cancer	0.00108	0.00211	CcSEcCtD
Nitrazepam—Nausea—Vincristine—lymphatic system cancer	0.00105	0.00205	CcSEcCtD
Nitrazepam—Nausea—Mitoxantrone—lymphatic system cancer	0.00103	0.002	CcSEcCtD
Nitrazepam—Vision blurred—Methotrexate—lymphatic system cancer	0.000993	0.00193	CcSEcCtD
Nitrazepam—Malaise—Methotrexate—lymphatic system cancer	0.00095	0.00185	CcSEcCtD
Nitrazepam—Vertigo—Methotrexate—lymphatic system cancer	0.000947	0.00184	CcSEcCtD
Nitrazepam—Leukopenia—Methotrexate—lymphatic system cancer	0.000943	0.00184	CcSEcCtD
Nitrazepam—Convulsion—Methotrexate—lymphatic system cancer	0.000913	0.00178	CcSEcCtD
Nitrazepam—Confusional state—Methotrexate—lymphatic system cancer	0.000867	0.00169	CcSEcCtD
Nitrazepam—Infection—Methotrexate—lymphatic system cancer	0.000854	0.00166	CcSEcCtD
Nitrazepam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000831	0.00162	CcSEcCtD
Nitrazepam—Hypotension—Methotrexate—lymphatic system cancer	0.000803	0.00156	CcSEcCtD
Nitrazepam—Paraesthesia—Methotrexate—lymphatic system cancer	0.000772	0.0015	CcSEcCtD
Nitrazepam—Dyspnoea—Methotrexate—lymphatic system cancer	0.000767	0.00149	CcSEcCtD
Nitrazepam—Somnolence—Methotrexate—lymphatic system cancer	0.000764	0.00149	CcSEcCtD
Nitrazepam—Dyspepsia—Methotrexate—lymphatic system cancer	0.000757	0.00147	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000742	0.00145	CcSEcCtD
Nitrazepam—Fatigue—Methotrexate—lymphatic system cancer	0.000741	0.00144	CcSEcCtD
Nitrazepam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000709	0.00138	CcSEcCtD
Nitrazepam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000634	0.00123	CcSEcCtD
Nitrazepam—Asthenia—Methotrexate—lymphatic system cancer	0.000617	0.0012	CcSEcCtD
Nitrazepam—Pruritus—Methotrexate—lymphatic system cancer	0.000608	0.00118	CcSEcCtD
Nitrazepam—Diarrhoea—Methotrexate—lymphatic system cancer	0.000588	0.00115	CcSEcCtD
Nitrazepam—Dizziness—Methotrexate—lymphatic system cancer	0.000569	0.00111	CcSEcCtD
Nitrazepam—Vomiting—Methotrexate—lymphatic system cancer	0.000547	0.00106	CcSEcCtD
Nitrazepam—Rash—Methotrexate—lymphatic system cancer	0.000542	0.00106	CcSEcCtD
Nitrazepam—Dermatitis—Methotrexate—lymphatic system cancer	0.000542	0.00105	CcSEcCtD
Nitrazepam—Headache—Methotrexate—lymphatic system cancer	0.000539	0.00105	CcSEcCtD
Nitrazepam—Nausea—Methotrexate—lymphatic system cancer	0.000511	0.000995	CcSEcCtD
